Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab

Carlos A. Cañas, Fabio Bonilla‐Abadía, Katherine Vallejo, Hector Mario Rengifo, Marco A. Gallón, Gabriel J. Tobón

Endocrine Metabolic & Immune Disorders - Drug Targets · 2018 · 15 citations · 0 references

Abstract

Tocilizumab could be an optional treatment in patients with TAO.